.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 6,858,618

« Back to Dashboard

Claims for Patent: 6,858,618

Title: Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia
Abstract:The invention provides a method for the treatment of heterozygous familial hypercholesterolemia by administering the compound (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrim idin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof.
Inventor(s): Raza; Ali (Cheshire, GB), Hutchinson; Howard Gerard (Delaware, DE)
Assignee: AstraZeneca AB (Sodertalje, SE)
Application Number:10/432,402
Patent Claims: 1. A method for treating heterozygous familial hypercholesterolemia in a patient suffering heterozygous familial hypercholesterolemia, comprising administering to the patient (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrim idin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof.

2. A method as claimed in claim 1 wherein the patient is suffering from severe heterozygous familial hypercholesterolemia.

3. A method as claimed in claim 1 wherein the patient also suffers one or more of the following conditions coronary heart disease, peripheral vascular disease and diabetes.

4. A method as claimed in claim 1 or claim 3 wherein the target LDL-C level for the patient suffering heterozygous familial hypercholesterolemia which is to be achieved by administering to the patient (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrim idin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof is less than or equal to .ltoreq.100 mg/dL.

5. A method as claimed in claim 4 wherein the calcium salt of (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrim idin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid is administered.

6. A method as claimed in claim 5 wherein 40 to 80 mg of (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrim idin-5-yl](3R,5 S)-3,5-dihydroxyhept-6-enoic acid is administered once a day to the patient in the form of the calcium salt.

7. A method as claimed in claim 5 wherein 80 mg of (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrim idin-5-yl](3R,5S)3,5-dihydroxyhept-6-enoic acid is administered once a day to the patient in the form of the calcium salt.

8. A method for reducing LDL-C, raising HDL-C, reducing Apo B and raising Apo A-I in a patient suffering from heterozygous familial hypercholesterolemia comprising administering to the subject (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrim idin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof.

9. A method as claimed in claim 1 wherein the patient has a fasting LDL-C level between 5.69 and <12.93 mmol/L.

10. A method as claimed in claim 9 wherein the patient has a fasting triglyceride level less than or equal to 4.52 mmol/L.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc